Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 7/12/11 → 7/12/14 |
Funding
- Novella Clinical, LLC (AT13387/0002 // AT13387/0002)
- Astex Therapeutics Ltd (AT13387/0002 // AT13387/0002)
Prot# AT13387/0002: An Open-Label Randomized, Multi-Centre, Phase II Study to Investigate the Safety and Efficacy of AT13387, either as Monotherapy or in Combination with Imatinib, in Patients with Unresectable and/or Metastatic Malignant GIST whose Tumou
- Agulnik, Mark (PD/PI)
Project: Research project